$872 Million is the total value of Slate Path Capital LP's 11 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 88.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSO | Sell | TESORO CORP | $219,762,000 | +5.2% | 2,260,000 | -8.7% | 25.20% | +10.5% |
| SPY | New | SPDR S&P 500 ETF TRput | $134,141,000 | – | 700,000 | +100.0% | 15.38% | – |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Dcl a new | $130,410,000 | +32.4% | 741,600 | +29.0% | 14.96% | +39.1% |
| GDX | New | MARKET VECTORS ETF TRgold miner etf | $94,394,000 | – | 6,870,000 | +100.0% | 10.82% | – |
| PODD | INSULET CORP | $70,475,000 | -16.4% | 2,720,000 | 0.0% | 8.08% | -12.2% | |
| YOKU | Sell | YOUKU TUDOU INCsponsored adr | $65,055,000 | -29.7% | 3,690,000 | -2.1% | 7.46% | -26.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $47,814,000 | -41.5% | 595,000 | -12.7% | 5.48% | -38.6% |
| TWC | New | TIME WARNER CABLE INC | $42,152,000 | – | 235,000 | +100.0% | 4.83% | – |
| Z | New | ZILLOW GROUP INCcl c cap stk | $27,945,000 | – | 1,035,000 | +100.0% | 3.20% | – |
| IPXL | Sell | IMPAX LABORATORIES INC | $25,879,000 | -69.3% | 735,000 | -59.9% | 2.97% | -67.7% |
| PYPL | New | PAYPAL HLDGS INC | $13,968,000 | – | 450,000 | +100.0% | 1.60% | – |
| P | Exit | PANDORA MEDIA INC | $0 | – | -1,800,000 | -100.0% | -3.06% | – |
| MPC | Exit | MARATHON PETE CORP | $0 | – | -1,800,000 | -100.0% | -10.28% | – |
| GOLD | Exit | BARRICK GOLD CORP | $0 | – | -13,450,000 | -100.0% | -15.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.